New York’s Horizons Psychedelic Conference Highlights Big Donations In The Growing Industry
Venture capitalist and businessman Stephen Jurvetson is joining an expanding group of prominent investors who are backing research into psychedelic ventures.
Sorrento Begins Enrollment In Phase 2 Trial Of Resiniferatoxin For The Treatment Of Pain Due To Knee Osteoarthritis
Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", , Sorrento", , )))) today announced that the Phase 2 clinical study of RTX for treating knee pain from osteoarthritis (OA) has begun enrollment. This study is a
Daré Bioscience’s One-Time Bacterial Vaginosis Treatment Scores FDA Approval
The FDA has approved Daré Bioscience Inc (NASDAQ:DARE) Xaciato (DARE-BV1) to treat bacterial vaginosis. Xaciato is a thermosetting bioadhesive hydrogel containing…
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
A British study evaluating mixing COVID-19 vaccines showed a better immune response in people after the first dose of AstraZeneca
Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19
The World Health Organization said that it's not recommending the use of convalescent plasma as a treatment for COVID-19 for mild or sev
Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJ
In a race with Merck & Co Inc (NYSE: MRK) to get antivirals to market, Pfizer Inc (NYSE: PFE) CEO Albert Bourla told the